All you need to get started with ETF selection and analysis. Create your account now →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

Start Comparing ETFs Now!

›ETF Providers›ARK Invest Europe›AAKG

AAKG

IE000O5M6XO1

Active ETF Equity ESG Theme: BioTech & Genomics

AAKG ETF · ARK Genomic Revolution UCITS ETF

The AAKG Exchange Traded Fund (ETF) is provided by ARK Invest Europe. This fund is actively managed; it does not track an index. The dividend policy is capitalization.

Real-time data unavailable for AAKG

LIVE

CLOSED

This fund is part ofWorld Blended Cap1M perf.+2.06%

Last price

N/A

1M perf.

-5.85%

1M flows

+€119K

AuM

€40M

E/R

0.75%

Rating

Not rated

ESG Consensus®

AAKG

N/A

Performance & flows

Segment for quartile rank

January 9, 2026 → April 9, 2026

Create a free account to view the flows graph

AAKG

$5.11

-10.57%

World Blended Cap

+0.73%

Historic performance and flows

	1M	3M	1Y	3Y	5Y	MTD	QTD	YTD
Perf.	-5.85%	-10.57%	+34.02%	N/A	N/A	+2.40%	+2.40%	-5.75%
Flows

Key fund info

Segment for quartile rank

Main characteristics

Issuer

ARK Invest Europe

ISIN

IE000O5M6XO1

AuM

€40M

E/R

0.75%

ESG Consensus®

More details

NAV

4/9/2026

$5.11

1D NAV change

-2.58%

Dividend policy

Capitalization

No. of holdings

Inception date

4/12/2024

Jurisdiction

Ireland

Distribution

Spain

Norway

Netherlands

Austria

United Kingdom

Legal structure

Irish Collective Asset-management Vehicle

Base currency

USD

Classification

Product type

Active ETF

Asset class

Equity

Factors

N/A

Investment strategy

ARK Genomic Revolution UCITS ETF is an exchange-traded fund incorporated in Ireland. The Fund will invest in companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to genomics revolution.

Tax optimisation

PEA

France

UK Reporting Status

United Kingdom

Create a free Trackinsight Essentials account to unlock insights

Access exclusive metrics and features to support your investment decisions.

Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.

Enterprise Fund page features include:

Legal documents

Powerful buy-list integration

Fund data exports

Advanced risk metrics

Advanced replication analysis

Advanced exposure look-through

Upload your own internal metrics

Custom data feature

See all Trackinsight Enterprise features

Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.

Learn more about Trackinsight Enterprise

Similar ETFs

ARKG

ARK Genomic Revolution ETF

1M perf.

-3.42%

E/R

0.75%

XBI

State Street SPDR S&P Biotech ETF

1M perf.

+1.55%

E/R

0.35%

CURE

Global X S&P Biotech ETF

1M perf.

+3.52%

E/R

0.45%

PTH

Invesco DWA Healthcare Momentum ETF

1M perf.

+2.26%

E/R

0.72%

XPH

State Street SPDR S&P Pharmaceuticals ETF

1M perf.

+0.42%

E/R

0.35%

Risk profile

Segment for quartile rank

Historical risk/return profile

	3M	1Y	3Y	5Y
Returns	-10.57%	+34.02%	N/A	N/A
Volatility
Perf./Volatility
Max drawdown

Create a free account to view risk/return table

Synthetic Risk and Reward Indicator (SRRI)

UCITS

PRIIPS

More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries

USA

91.20%

Switzerland

8.80%

Sectors

Health Care

85.74%

Information Technology

1.19%

Unavailable

13.07%

Diversification

Total weight of top 15 holdings out of 35

Top 15 holdings

Data as of February 28, 2026

TWIST BIOSCIENCE CORP

CRISPR THERAPEUTICS

US88023B1035

BEAM THERAPEUTICS

PERSONALIS INC

10X GENOMICS INC

NATERA

INTELLIA THERAPEUTICS INC

Create a free account to view top holdings

ILLUMINA

RECURSION PHARMACEUTICALS

CAREDX INC/D

VERACYTE INC/D

ABSCI

GUARDANT HEALTH INC

IONIS PHARMACEUTICALS INC

Create a free account to view top holdings

More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria

Yes

SDG

More sustainability metrics are available, exclusively in Trackinsight Enterprise

Issuer

ARK Invest Europe

ARK Invest Europe ID Card

Number of funds

Total AuM

€885M

Expense ratio range

0.45% - 0.75%

Average expense ratio

0.58%

View all ARK Invest Europe funds

Top 5 funds by ARK Invest Europe

		AuM
AAKI	ARK Artificial Intelligence & Robotics UCITS ETF	€249M
ARXK	ARK Innovation UCITS ETF	€231M
WRLD	Rize Environmental Impact 100 UCITS ETF	€113M
CYBR	Rize Cybersecurity and Data Privacy UCITS ETF	€82M
RIZF	Rize Sustainable Future of Food UCITS ETF	€72M

The details about this provider will be added soon.

Frequently asked questions about AAKG

What does ARK Genomic Revolution UCITS ETF, AAKG, invest in?

AAKG is a Active ETF. This ETF provides exposure to Other Equities.

What is the Total Expense ratio (TER) of AAKG?

AAKG carries a total expense ratio (TER) of 0.75%, indicating the annual cost for holding the fund.

When was AAKG launched?

AAKG was introduced to the market on April 12, 2024. It trades on Spain, among other exchanges

Who is the ETF issuer of AAKG?

ARK Genomic Revolution UCITS ETF, AAKG, is provided by ARK Invest Europe. Learn more about ARK Invest Europe here.

What is the current assets under management (AUM) of AAKG?

AAKG oversees €40M in assets as of April 9, 2026.

How has AAKG performed lately?

Based on data from April 9, 2026, AAKG returned -5.85% over the past month, -10.57% over the last three months and -5.75% year-to-date.

What are the latest inflows or outflows for AAKG?

As of April 9, 2026, AAKG recorded net flows of +€126K over the last month and +€6.1M year-to-date.

Does AAKG distribute dividends?

AAKG follows a capitalizing, meaning it reinvests income within the fund.

What are the main country or region exposures of AAKG?

As of February 28, 2026, AAKG has significant geographic allocations in USA and Switzerland.

In which sector or theme does AAKG invest in?

As of February 28, 2026, AAKG focuses largely on Health Care and Information Technology.

How many securities does AAKG hold and how diversified is it?

As of February 28, 2026, AAKG holds 35 positions in its portfolio, with 73.72% of assets concentrated in its top 15 holdings.

What are the main positions in AAKG?

As of February 28, 2026, AAKG top three holdings include TWIST BIOSCIENCE CORP, CRISPR THERAPEUTICS and US88023B1035.

What is the base currency of AAKG?

The base currency of AAKG is USD.

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The Ultimate ETF Comparison Tool - Try Now!

AAKG ETF · ARK Genomic Revolution UCITS ETF

Performance & flows

Historic performance and flows

Monthly performance and flows

Trading and listing info

Key fund info

Enterprise

Similar ETFs

Risk profile

Historical risk/return profile

Exposure

Sustainability

Issuer

Frequently asked questions about AAKG

What does ARK Genomic Revolution UCITS ETF, AAKG, invest in?

AAKG is a Active ETF. This ETF provides exposure to Other Equities.

What is the Total Expense ratio (TER) of AAKG?

AAKG carries a total expense ratio (TER) of 0.75%, indicating the annual cost for holding the fund.

When was AAKG launched?

AAKG was introduced to the market on April 12, 2024. It trades on Spain, among other exchanges

Who is the ETF issuer of AAKG?

ARK Genomic Revolution UCITS ETF, AAKG, is provided by ARK Invest Europe. Learn more about ARK Invest Europe here.

What is the current assets under management (AUM) of AAKG?

AAKG oversees €40M in assets as of April 9, 2026.

How has AAKG performed lately?

Based on data from April 9, 2026, AAKG returned -5.85% over the past month, -10.57% over the last three months and -5.75% year-to-date.

What are the latest inflows or outflows for AAKG?

As of April 9, 2026, AAKG recorded net flows of +€126K over the last month and +€6.1M year-to-date.

Does AAKG distribute dividends?

AAKG follows a capitalizing, meaning it reinvests income within the fund.

What are the main country or region exposures of AAKG?

As of February 28, 2026, AAKG has significant geographic allocations in USA and Switzerland.

In which sector or theme does AAKG invest in?

As of February 28, 2026, AAKG focuses largely on Health Care and Information Technology.

How many securities does AAKG hold and how diversified is it?

As of February 28, 2026, AAKG holds 35 positions in its portfolio, with 73.72% of assets concentrated in its top 15 holdings.

What are the main positions in AAKG?

As of February 28, 2026, AAKG top three holdings include TWIST BIOSCIENCE CORP, CRISPR THERAPEUTICS and US88023B1035.

What is the base currency of AAKG?

The base currency of AAKG is USD.

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US